The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 378, Issue 1, 2008, Pages 103-116

  Myslivecek, Jaromir ^a   Klein, Martin ^a   Novakova, Martina ^a   Ricny, Jan ^b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Heart; Immunoprecipitation; MT7 mamba toxin; Muscarinic receptors; Non M2 muscarinic receptor; PLC activity

Indexed keywords

11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; 8 METHYL 8 AZABICYCLO 3 ENDO[3.2.1]OCT 3 YL 1,4 DIHYDRO 2 OXO 3(2H) QUINAZOLINECARBOXYLIC ACID ESTER; AMIDE; HEXAHYDROSILADIFENIDOL; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; OTENZEPAD; PHOSPHOLIPASE C; PIRENZEPINE; QUINAZOLINE DERIVATIVE; SNAKE VENOM; TRIPINAMIDE; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; HEART ATRIUM; HEART VENTRICLE; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; ANIMAL; DRUG EFFECT; GENE EXPRESSION; MALE; METABOLISM; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; GENE EXPRESSION; HEART ATRIA; HEART VENTRICLES; MALE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M5; RECEPTORS, MUSCARINIC; TYPE C PHOSPHOLIPASES;

EID: 45849092563     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0285-8     Document Type: Article

References (60)

1. Adem A, Asblom A, Johnasson G, Mbuga PM, Karlsson E (1988) Toxins from the venom of the green mamba dendroaspis angusticeps that inhibit the binding of quinuclinidil benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta 968:340-345
2. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716-723
3. Birk E, Riemer RK (1992) Myocardial cholinergic signaling changes with age. Pediatr Res 31:601-605
4. Bolognesi ML, Minarini A, Budriesi R, Cacciaguerra S, Chiarini A, Spampinato S, Tumiatti V, Melchiorre C (1998) Universal template approach to drug design: polyamines as selective muscarinic receptor Antagonists. J Med Chem 41:4150-4160
5. Borda ES, Perez Leiros C, Camusso JJ, Bacman S, Sterin-Borda L (1997) Differential cholinoceptor subtype-dependent activation of signal transduction pathways in neonatal versus adult rat atria. Biochem Pharmacol 53:959-967
6. Brodde O-E, Bruck H, Leineweber K, Seyfarth T (2001) Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528-538
7. Brown SL, Brown JH (1983) Muscarinic stimulation of phosphatidylinositol metabolism in atria. Mol Pharmacol 24:351-356
8. Buckley NJ, Hulme EC, Birdsall NJ (1990) Use of clonal cell lines in the analysis of neurotransmitter receptor mechanisms and function. Biochim Biophys Acta 1055:43-53
9. Camusso JJ, Sterin-Borda L, Rodriguez M, Bacman S, Borda E (1995) Pharmacological evidence for the existence of different subtypes of muscarinic acetylcholine receptors for phosphoinositide hydrolysis in neonatal versus adult rat atria. J Lipid Mediat Cell Signal 12:1-10
10. Carsi J, Potter LT (2000) M1-toxin isotoxins from the green mamba (Dendroaspis Angusticeps) that selectively block M1 muscarinic receptors. Toxicon 38:187-198
11. Caulfield MP, Birdsal NJM (1998) International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290
12. Choppin A, Stepan GJ, Loury DN, Watson N, Eglen RM (1999) Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats. Br J Pharmacol 127:1551-1558
13. Colecraft HM, Egamino JP, Sharma VK, Sheu S-S (1998) Signaling mechanisms underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells. J Biol Chem 73:32158-32166
14. Dhein S, van Koppen CJ, Brodde OE (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44:161-182
15. Dobrev D, Knuschke D, Richter F, Wettwer E, Christ T, Knaut M, Ravens U (2002) Functional identification of m1 and m3 muscarinic acetylcholine receptors in human atrial myocytes: influence of chronic atrial fibrillation. Circulation 106(Suppl):11-154
16. Doods HN, Willim KD, Boddeke HW, Entzeroth M (1993) Characterization of muscarinic receptors in guinea-pig uterus. Eur J Pharmacol 250:223-230
17. Doods HN, Entzeroth M, Ziegler H, Mayer N, Holzer P (1994) Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. Eur J Pharmacol 253:275-281
18. Dwivedi Y, Pandey GN (1999) Repeated administration of dexamethasone increases phosphoinositide-specific phospholipase C activity and mRNA and protein expression of the phospholipase C beta 1 isozyme in rat brain. J Neurochem 73:780-790
19. Eglen RM, Nahorski SR (2000) The muscarinic M(5) receptor: a silent or emerging subtype? Br J Pharmacol 130:13-21
20. Fisher JT, Vincent SG, Gomeza J, Yamada M, Wess J (2004) Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J 18:711-713
21. Ford APDW, Eglen RM, Whiting RL (1992) Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in Guinea pig cardiac muscle. Eur J Pharmacol Mol Pharmacol Section 225:105-112
22. Gallo MP, Alloatti G, Carola E, Oberto A, Cesare Levi R (1993) -1 muscarinic receptors increase calcium current and phosphoinositide turnover in Guinea-pig ventricular cardiocytes. J Physiol (London) 471:41-60
23. 2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:1692-1697
24. Hardouin SN, Richmond KN, Zimmerman A, Hamilton SE, Feigl EO, Nathanson NM (2002) Altered cardiovascular responses in mice lacking the M1 muscarinic acetylcholine receptor. J Pharmacol Exp Ther 301:129-137
25. Hassal CJS, Stanford SC, Burnstok G, Buckley NJ (1993) Co-expression of four muscarinic receptor genes by the intrinsic neurons of the rat and Guinea-pig heart. Neuroscience 56:1041-1048
26. 3 receptor subtype gene expression in the human heart. Cell Mol Life Sci 57:175-180
27. Hoower DB, Baisden RH, Ximoy SX (1994) Localization of muscarinic receptor MRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. Circ Res 75:813-820
28. 5 subtypes of muscarinic receptors in rat heart and brain cortex. Mol Pharmacol 61:1267-1272
29. Lazareno S, Gharagozloo P, Kuonen D, Popham A, Birdsall NJ (1998) Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Mol Pharmacol 53:573-589
30. Levey AI, Stormann TM, Brann MR (1990) Bacterial expression of human muscarinic receptor fusion proteins and generation of subtype-specific antisera. FEBS Lett 275:65-69
31. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226
32. Li M, Yasuda RP, Wall SJ, Wellstein A, Wolfe BB (1991) Distribution of M2 muscarinic receptors in rat brain using antisera selective for M3 receptors. Mol Pharmacol 40:28-35
33. Luthin GR, Harkness J, Artymyshyn RP, Wolfe BR (1988) Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Mol Pharmacol 34:327-333
34. Max SI, Liang JS, Potter LT (1993) Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol 44:1171-1175
35. Mayanil CSK, Richardson RM, Hosey MM (1991) Subtype-specific antibodies for muscarinic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes. Mol Pharmacol 40:900-907
36. Meyer T, Wellner-Kienitz MC, Biewald A, Bender K, Eickel A, Pott L (2001) Depletion of phosphatidylinositol 4,5-bisphosphate by activation of phospholipase C-coupled receptors causes slow inhibition but not desensitization of G protein-gated inward rectifier K+ current in atrial myocytes. J Biol Chem 276:5650-5658
37. Moscona-Amir E, Henis YI, Sokolovsky M (1989) Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of CAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis. Biochemistry 28:7130-7137
38. Mysliveček J, Říčný J, Kolář F, Tuček S (2003) The effects of hydrocortisone treatment on the rat heart muscarinic and adrenergic a1, b1 and b2 receptors, propranolol-resistant binding sites and on some consequent steps in intracellular signaling. NS Arch Pharmacol 368:366-376
39. Mysliveček J, Říčný J, Palkovits M, Kvetňanský R (2004) The effects of short-term immobilization stress on muscarinic receptors, beta-adrenoceptors and adenylyl cyclase In different heart regions. Ann NY Acad Sci 1018:315-322
40. Myslivecek J, Novakova M, Palkovits M, Krizanova O, Kvetnansky R (2006) Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart. Life Sci 79:112-120
41. Nadler E, Barnea O, Vidne B, Isakov A, Shavit G (1993) Positive inotropic effect in the heart produced by acetylcholine. J Basic Clin Physiol Pharmacol 4:229-248
42. Oberhauser V, Schwertfeger E, Rutz T, Beyersdorf F, Rump LC (2001) Acetylcholine release in human heart atrium. Influence of muscarinic acetylcholine autoreceptors, diabetes, and age. Circulation 103:1638-1643
43. 1-selective ligand muscarinic toxin 7 (MT-7). Br J Pharmacol 131:447-452
44. Perez CC, Tobar ID, Jimenez E, Castaneda D, Rivero MB, Concepcion JL, Chiurillo MA, Bonfante-Cabarcas R (2006) Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves. Pharmacol Res 54:345-355
45. Ponicke K, Heinroth-Hoffmann I, Brodde OE (2003) Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br J Pharmacol 138:156-160
46. Reever CM, Ferrari-DiLeo G, Flynn DD (1997) The M5 (m5) receptor subtype: fact or fiction? Life Sci 60:1105-1112
47. 1 muscarinic acetylcholine receptors in rat ventricular myocytes. Circ Res 79:86-93
48. Shi H, Wang H, Wang Z (1999) Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts. Mol Pharmacol 55:497-507
49. Sterin-Borda L, Echague AV, Leiros CP, Genaro A, Borda E (1995) Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol 115:1525-1531
50. Sun LS, Huber F, Robinson RB, Bilezikian JP, Steinberg SF, Vulliemoz Y (1996) Muscarinic receptor heterogeneity in neonatal rat ventricular myocytes in culture. J Cardiovasc Pharmacol 27:455-461
51. Trendelenburg AU, Gomeza J, Klebroff W, Zhou H, Wess J (2003) Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice. Br J Pharmacol 138:469-480
52. Trendelenburg AU, Meyer A, Wess J, Starke K (2005) Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice. Br J Pharmacol 145:1153-1159
53. Wall SJ, Yasuda RP, Hory F, Flagg S, Martin BM, Ginnis EI, Wolfe BB (1991a) Production of antisera selective for M1 muscarinic receptors using fusion proteins: distribution of M1 receptors in rat brain. Mol Pharmacol 39:643-649
54. Wall SJ, Yasuda RP, Li M, Wolfe BB (1991b) Development of an antiserum against M3 muscarinic receptors: distribution of M3 receptors in rat tissues and clonal cell lines. Mol Pharmacol 40:783-789
55. Wang HZ, Han H, Zhang LM, Si H, Schram G, Nattel S, Wang ZG (2001) Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human geart. Mol Pharmacol 59:1029-1036
56. 3 muscarinic acetylcholine receptors in mammalian hearts. Br J Pharmacol 142:395-408
57. Wang H, Lu Y, Wan Z (2007) Function of cardiac M3 receptors. Autonom Autacoid Pharmacol 27:1-11
58. Willmy-Matthes P, Leineweber K, Wangemann T, Silber RE, Brodde OE (2003) Existence of functional M3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch Pharmacol 368:316-319
59. Yang CM, Chen F-F, Sung T-C, Hsu H-F, Wu D (1993) Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes. Am J Physiol 265:C666-C673
60. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, Wolfe BB (1992) Development of antisera selective for M4 and M5 muscarinic cholinergic receptors: distribution of M4 and M5 receptors in rat brain. Mol Pharmacol 43:149-157